Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

By R. Dienstmann, Louis Vermeulen, Justin Guinney, S. Kopetz, S. Tejpar, J. Tabernero. Nature Reviews. Cancer, 2017

896 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/b1d3efe6e09a3bd6fc8f59c509259c0504c21c75

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. William Y. Kim
2. E. Gibb

In Oncology

1. John N. Weinstein
2. J. Bellmunt

In Pathology and Forensic Medicine

1. John N. Weinstein

Citations in the corpus

• Precision Oncology: The Road Ahead (2017, background): “Initial molecular subtype studies have often focused on clustering samples into subtypes based on gene expression in a single cancer type, which have provided robust biomarkers and subgroups, coherent with patient survival profiles (e.g, in breast cancer [85] or colorectal cancer (CRC) [86]).”
• A Consensus Molecular Classification of Muscle-invasive Bladder Cancer (2019, positive): “The four Consensus Molecular Subtypes (CMS) identified in that work have helped frame the development of colorectal cancer precision medicine (Dienstmann et al., 2017) and are now being evaluated in clinical trials (Lenz et al.”